Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Conditions

Colorectal Neoplasms 19Carcinoma, Non-Small-Cell Lung 19Breast Neoplasms 17Lung Neoplasms 15Colonic Neoplasms 11Head and Neck Neoplasms 9Rectal Neoplasms 7Glioblastoma 5Prostatic Neoplasms 4Precancerous Conditions 4Mouth Neoplasms 4Esophageal Neoplasms 4Central Nervous System Neoplasms 4Adenomatous Polyposis Coli 4Uterine Cervical Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3Sarcoma 3Neuroblastoma 3Neoplasms 3Liver Neoplasms 3Gliosarcoma 3Glioma 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Smoking 2Salivary Gland Neoplasms 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2Multiple Myeloma 2

Interventions

Tobacco Use Cessation Devices 4Surveys and Questionnaires 4Varenicline 2Tobacco Products 2Smoking Devices 2Ethanol 2Celecoxib 2zileuton 1olaparib 1Yoga 1Vitamin B 12 1Transcranial Direct Current Stimulation 1Restraint, Physical 1Radon 1Radiotherapy 1Patient Navigation 1Nicotine Replacement Therapy 1Motivational Interviewing 1Mindfulness-Based Stress Reduction 1Mindfulness 1Interviews as Topic 1Health 1Folic Acid 1Erlotinib Hydrochloride 1Cycloserine 1Cognitive Behavioral Therapy 1Cetuximab 1Bupropion 1Budesonide 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Smoking × Celecoxib × Clear all
NCT01021215 2015-04-02

Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers

National Cancer Institute (NCI)

Phase 1/2 Completed
84 enrolled 10 charts

Smoking, Tobacco Use Disorder

NCT00981201 2012-08-01

Celecoxib as a Chemopreventive Agent in Current and Former Smokers

M.D. Anderson Cancer Center

Phase 3 Completed
219 enrolled

Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡